Literature DB >> 6155335

Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin.

P M Schlievert, K M Bettin, D W Watson.   

Abstract

Group A streptococcal pyrogenic exotoxins (SPEs) A, B, and C and alpha-amanitin enhance host susceptibility to lethal endotoxin shock. The capacity of SPE C and alpha-amanitin to prepare rabbits for the enhancement phenomenon required pretreatment of the animals 1 to 2 h before giving endotoxin. Endotoxin clearance from the circulation of rabbits pretreated with either SPE C or alpha-amanitin was reduced. Even at the time of death, significant amounts of endotoxin remained in the circulation. It is proposed that the SPE and alpha-amanitin inhibit ribonucleic acid synthesis in Kupffer cells with concomitant alteration in reticuloendothelial clearnace function, allowing endotoxin to persist in the circulation and produce host injury. All three SPE types and alpha-amanitin inhibited ribonucleic acid synthesis by 50% or greater in whole liver cells. Kupffer cells, liver cell nuclei, and liver nuclear extracts; inhibition was observed liver cells from both mice and rabbits. The inhibitory effect by SPEs was dose dependent and was observed after as little as 15 min of preincubation with liver cells. The content of ribonucleic acid in liver nuclei of mice pretreated with either SPE C or alpha-amanitan was reduced, whereas total deoxyribonucleic acid and protein content remained unaltered.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155335      PMCID: PMC550799          DOI: 10.1128/iai.27.2.542-548.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate.

Authors:  H W Seyberth; H Schmidt-Gayk; E Hackenthal
Journal:  Toxicon       Date:  1972-08       Impact factor: 3.033

2.  A procedure for the isolation of enzymically active rat-liver nuclei.

Authors:  C C Widnell; J R Tata
Journal:  Biochem J       Date:  1964-08       Impact factor: 3.857

Review 3.  Poisonous principles of mushrooms of the genus Amanita. Four-carbon amines acting on the central nervous system and cell-destroying cyclic peptides are produced.

Authors:  T Wieland
Journal:  Science       Date:  1968-03-01       Impact factor: 47.728

4.  Altered characteristics of mammalian RNA polymerase following solubilization from nuclei.

Authors:  S T Jacob; E M Sajdel; H N Munro
Journal:  Biochem Biophys Res Commun       Date:  1968-09-06       Impact factor: 3.575

5.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

6.  Decreased RNA content in mouse liver nuclei after intoxication with alpha-amanitin.

Authors:  L Fiume; F Stirpe
Journal:  Biochim Biophys Acta       Date:  1966-09

7.  Biologically active endotoxins from Salmonella mutants deficient in O- and R-polysaccharides and heptose.

Authors:  Y B Kim; D W Watson
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

8.  Enhanced toxicity for mice of combinations of antibiotics with Escherichia coli cells or Salmonella typhosa endotoxin.

Authors:  W C Rose; S G Bradley
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

9.  Effect of lead acetate on the susceptibility of rats to bacterial endotoxins.

Authors:  H Selye; B Tuchweber; L Bertók
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

10.  Studies on the mode of action of diphtheria toxin. VII. Toxin-stimulated hydrolysis of nicotinamide adenine dinucleotide in mammalian cell extracts.

Authors:  D M Gill; A M Pappenheimer; R Brown; J T Kurnick
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin.

Authors:  B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.

Authors:  M Roggiani; J A Stoehr; B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Physiology of the potentiation of lethal endotoxin shock by streptococcal pyrogenic exotoxin in rabbits.

Authors:  T Murai; Y Ogawa; H Kawasaki; S Kanoh
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

5.  Effects of carrier ampholyte contamination on the biological and biochemical properties of streptococcal pyrogenic exotoxin type C.

Authors:  T G Bloomster; D W Watson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

Review 7.  Models matter: the search for an effective Staphylococcus aureus vaccine.

Authors:  Wilmara Salgado-Pabón; Patrick M Schlievert
Journal:  Nat Rev Microbiol       Date:  2014-07-07       Impact factor: 60.633

8.  Activation of murine T-suppressor lymphocytes by group A streptococcal and staphylococcal pyurogenic exotoxins.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

Review 9.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

10.  Gastrointestinal Mucormycosis following a Streptococcus pyogenes Toxic Shock Syndrome in a Previously Healthy Patient: A Case Report.

Authors:  Jean-François Roussy; Catherine Allard; Guy St-Germain; Jacques Pépin
Journal:  Case Rep Infect Dis       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.